IO Biotech, Inc.
General ticker "IOBT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $76.6M (TTM average)
IO Biotech, Inc. follows the US Stock Market performance with the rate: 7.8%.
Estimated limits based on current volatility of 6.0%: low 0.63$, high 0.71$
Factors to consider:
- Total employees count: 57 (+78.1%) as of 2022
- Top business risk factors: Limited operating history, Economic downturns and volatility, Geopolitical risks, Strategic risks and growth management, Currency fluctuations
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.61$, 1.74$]
- 2025-12-31 to 2026-12-31 estimated range: [0.60$, 1.68$]
Financial Metrics affecting the IOBT estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -142.79 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 69.45 > 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term IOBT quotes
Long-term IOBT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $71.42MM | $91.44MM | $95.18MM |
| Operating Income | $-71.42MM | $-91.44MM | $-95.18MM |
| Non-Operating Income | $1.24MM | $6.21MM | $1.13MM |
| Interest Expense | $0.30MM | $0.00MM | $0.00MM |
| R&D Expense | $46.99MM | $67.83MM | $71.48MM |
| Income(Loss) | $-70.19MM | $-85.23MM | $-94.05MM |
| Taxes | $1.27MM | $0.85MM | $1.44MM |
| Profit(Loss)* | $-71.46MM | $-86.08MM | $-95.49MM |
| Stockholders Equity | $138.85MM | $133.16MM | $47.02MM |
| Assets | $151.81MM | $150.72MM | $67.70MM |
| Operating Cash Flow | $-59.73MM | $-71.74MM | $-82.35MM |
| Capital expenditure | $0.69MM | $0.32MM | $0.04MM |
| Investing Cash Flow | $-0.69MM | $-0.32MM | $-0.04MM |
| Financing Cash Flow | $0.00MM | $71.86MM | $0.00MM |
| Earnings Per Share** | $-2.48 | $-1.98 | $-1.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.